Reuters
@Reuters·4.2M subscribers·86.9K videos
LIVE: Reuters NEXT Newsmaker with Genentech CEO Ashley Magargee
Posted
March 16, 2026
Views
1,712
Likes
20
Engagement
1.17%
March 16, 2026
1,712
20
1.17%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
See what was published immediately before and after this episode.
59:15Now PlayingGenentech, the U.S.based pioneering biotechnology company owned by Switzerlandbased Roche, has been at the forefront of the development of complex biologic medicines used to treat conditions ranging from cancer to multiple sclerosis. It recently joined more than a dozen other pharmaceutical companies in striking a deal with the U.S. Administration to slash prices of some prescription medicines for some government programs and offer its flu medicines directly to customers via the new website. CEO Ashley Magargee, who has helmed Genentech for two years, joined fellow health industry CEOs and President Trump for the White House announcement.
Reuters Global Pharma Editor Michele Gershberg sits down with Magargee at Pharma USA 2026 in Philadelphia to discuss the sweeping shifts underway in U.S. and global health policy, the growing influence of AI on drug discovery and regulatory pathways, and the next generation of promising treatments poised to reshape medical practice.
#AshleyMagargee #Genentech #MicheleGershberg #PharmaUSA2026 #ReutersNEXTNewsmaker #ReutersNewsmaker #live #Reuters #news
Keep up with the latest news from around the world
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
